IUPAC Name: | 2,2-dimethylpropanethioamide |
Description: | 2,2,2-Trimethylthioacetamide (CAS# 630-22-8) is used as a reagent to synthesize Dabrafenib, an inhibitor of BRAF kinase that is used to treat BRAF V600-mutation positive carcinoma. BRAF is a gene that mediates cell growth and is activated by mutations caused by cancer. 2,2-Dimethylthiopropionamide is also used as a reagent to prepare sulfonyl-substituted 4,5-diarylthiazoles, compounds that act as cyclooxygenase-2 inhibitors (anti-inflammatory agents). |
Molecular Weight: | 117.21 |
Molecular Formula: | C5H11NS |
Canonical SMILES: | CC(C)(C)C(=S)N |
InChI: | InChI=1S/C5H11NS/c1-5(2,3)4(6)7/h1-3H3,(H2,6,7) |
InChI Key: | FJZJUSOFGBXHCV-UHFFFAOYSA-N |
Boiling Point: | 162.1 °C at 760 mmHg |
Density: | 0.978 g/cm3 |
LogP: | 2.01890 |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Sulfur Compounds
3-(1,3-Dimethylpyrazol-4-yl)-5-[(1-methylpyrazol-4-yl)methylidene]-2-sulfanylideneimidazolidin-4-one
Customers Also Viewed
Copyright © 2024 BOC Sciences. All rights reserved.
Our Products